SCAVENGING EFFECT OF SILIPIDE, A NEW SILYBIN-PHOSPHOLIPID COMPLEX, ON ETHANOL-DERIVED FREE-RADICALS

被引:67
作者
COMOGLIO, A
TOMASI, A
MALANDRINO, S
POLI, G
ALBANO, E
机构
[1] UNIV TURIN,DEPT EXPTL MED & ONCOL,TURIN,ITALY
[2] UNIV TURIN,DIPARTIMENTO SCI MED,TURIN,ITALY
[3] CNR,CTR IMMUNOGENET & EXPTL ONCOL,TURIN,ITALY
[4] INDENA SPA,I-20141 MILAN,ITALY
[5] UNIV MODENA,INST GEN PATHOL,I-41100 MODENA,ITALY
关键词
SILIPIDE; FREE RADICAL; ETHANOL; CYTOCHROME P4502E1; SILYBIN; SPIN TRAP;
D O I
10.1016/0006-2952(95)02001-S
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ethanol metabolism by cytochrome P4502E1 (CYP2E1) produces free radical intermediates, identified as hydroxyethyl radicals. We have observed that in vitro addition or in vivo pretreatment of rats with Silipide, a new 1:1 complex of silybin with phosphatidyl-choline, is able to decrease the spin trapping of hydroxyethyl radicals in microsomes from chronic alcohol-fed rats. This effect is not due to an interference with the metabolism of ethanol by CYP2E1, but is rather related to the capacity of the silybin molecule to scavenge hydroxyethyl radicals. However, such an effect is lost when pure silybin in amounts comparable to those present in Silipide is administered instead, due to the low bioavailability of uncomplexed flavonoid. Further experiments in vivo have shown that Silipide administration also decreases hydroxyethyl radical signals detectable in the bile of rats acutely treated with ethanol. The ability of Silipide to scavenge ethanol-derived radicals along with its antioxidant activity suggests that this drug might be potentially useful in counteracting free radical-mediated injuries involved in the development of liver damage caused by alcohol abuse.
引用
收藏
页码:1313 / 1316
页数:4
相关论文
共 27 条
[1]  
ALBANO E, 1994, METHODS ENZYMOL, V233, P117
[2]   ROLE OF ETHANOL-INDUCIBLE CYTOCHROME-P450 (P450IIE1) IN CATALYZING THE FREE-RADICAL ACTIVATION OF ALIPHATIC-ALCOHOLS [J].
ALBANO, E ;
TOMASI, A ;
PERSSON, JO ;
TERELIUS, Y ;
GORIAGATTI, L ;
INGELMANSUNDBERG, M ;
DIANZANI, MU .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (12) :1895-1902
[3]  
ALBANO E, 1993, ALCOHOL ALCOHOLISM, V28, P453
[4]   PHARMACOKINETIC STUDIES ON IDB-1016, A SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX, IN HEALTHY-HUMAN SUBJECTS [J].
BARZAGHI, N ;
CREMA, F ;
GATTI, G ;
PIFFERI, G ;
PERUCCA, E .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (04) :333-338
[5]   LIPID-PEROXIDATION AND IRREVERSIBLE DAMAGE IN THE RAT HEPATOCYTE MODEL - PROTECTION BY THE SILYBIN PHOSPHOLIPID COMPLEX IDB-1016 [J].
CARINI, R ;
COMOGLIO, A ;
ALBANO, E ;
POLI, G .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (10) :2111-2115
[6]   MONITORING OXIDATIVE DAMAGE IN PATIENTS WITH LIVER-CIRRHOSIS AND DIFFERENT DAILY ALCOHOL INTAKE [J].
CLOT, P ;
TABONE, M ;
ARICO, S ;
ALBANO, E .
GUT, 1994, 35 (11) :1637-1643
[7]  
CLOT P, 1995, GASTRONETEROL, V107
[8]   STUDIES ON THE ANTIOXIDANT AND FREE-RADICAL SCAVENGING PROPERTIES OF IDB-1016 A NEW FLAVANOLIGNAN COMPLEX [J].
COMOGLIO, A ;
LEONARDUZZI, G ;
CARINI, R ;
BUSOLIN, D ;
BASAGA, H ;
ALBANO, E ;
TOMASI, A ;
POLI, G ;
MORAZZONI, P ;
MAGISTRETTI, MJ .
FREE RADICAL RESEARCH COMMUNICATIONS, 1990, 11 (1-3) :109-115
[9]   RANDOMIZED CONTROLLED TRIAL OF SILYMARIN TREATMENT IN PATIENTS WITH CIRRHOSIS OF THE LIVER [J].
FERENCI, P ;
DRAGOSICS, B ;
DITTRICH, H ;
FRANK, H ;
BENDA, L ;
LOCHS, H ;
MERYN, S ;
BASE, W ;
SCHNEIDER, B .
JOURNAL OF HEPATOLOGY, 1989, 9 (01) :105-113
[10]  
FRENCH SW, 1993, EXP MOL PATHOL, V58, P71